Cargando…

Spermatogenesis of Male Patients with Congenital Hypogonadotropic Hypogonadism Receiving Pulsatile Gonadotropin-Releasing Hormone Therapy Versus Gonadotropin Therapy: A Systematic Review and Meta-Analysis

PURPOSE: Pulsatile gonadotropin-releasing hormone (GnRH) therapy and gonadotropin therapy (GT) were widely used for male patients with congenital hypogonadotropic hypogonadism (CHH), but their efficacy was not well compared before. We conducted this meta-analysis to compare the efficacy of restoring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Chao, Long, Gongwei, Zhang, Yucong, Wang, Tao, Wang, Shaogang, Liu, Jihong, Ma, Delin, Liu, Xiaming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Sexual Medicine and Andrology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443979/ https://www.ncbi.nlm.nih.gov/pubmed/32777865 http://dx.doi.org/10.5534/wjmh.200043

Ejemplares similares

Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism
por: Mao, Jiang-Feng, et al.
Publicado: (2017)

The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men
por: Zhang, Luyao, et al.
Publicado: (2018)

Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study
por: Hao, Ming, et al.
Publicado: (2021)

Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism
por: Ortac, Mazhar, et al.
Publicado: (2019)

The initiation and maintenance of gonadotropin-releasing hormone neuron identity in congenital hypogonadotropic hypogonadism
por: Chung, Wilson CJ, et al.
Publicado: (2023)

Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients
por: Hao, Ming, et al.
Publicado: (2019)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

MON-LB051 Non-inferiority Clinical Trial on Gonadotropinversus Pulsatile Gonadotropin-releasing Hormone Infusion Therapy in Male Adolescent Patient with Congenital Hypogonadotropic Hypogonadism
por: Liu, Ying
Publicado: (2019)

Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism
por: Fanis, Pavlos, et al.
Publicado: (2023)

AB029. The beneficial effects of pulsatile gonadotropin-releasing hormone pumps in the treatment of adult male idiopathic hypogonadotropic hypogonadism
por: Li, Yan-Feng, et al.
Publicado: (2018)

Management Outcomes in Males With Hypogonadotropic Hypogonadism Treated With Gonadotropins
por: Sahib, Bahaa O, et al.
Publicado: (2023)

Growth and descent of the testes in infants with hypogonadotropic hypogonadism receiving subcutaneous gonadotropin infusion
por: Lambert, Anne-Sophie, et al.
Publicado: (2016)

Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols
por: Sato, Naoko, et al.
Publicado: (2015)

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
por: Chen, Yin-Wei, et al.
Publicado: (2019)

Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients
por: Liu, Zhaoxiang, et al.
Publicado: (2016)

Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism
por: Mao, Jiang-Feng, et al.
Publicado: (2018)

ODP400 A Mutation in the Gonadotropin Releasing Hormone Receptor Associated with Congenital Hypogonadotropic Hypogonadism with Absence of Uterus and Ovaries
por: Alabi, Omolabake, et al.
Publicado: (2022)

Induction of spermatogenesis in men with hypogonadotropic hypogonadism
por: Morris, Guy C., et al.
Publicado: (2021)

MON-273 Retrospective Analysis of Gonadotropin-Mediated Pubertal Induction in Male Patients with Congenital Hypogonadotropic Hypogonadism (CHH)
por: Cangiano, Biagio, et al.
Publicado: (2020)

SUN-092 Effect of Pubertal Induction with Gonadotropins and GnRH Therapy in Male Hypogonadotropic Hypogonadism: Meta-Analysis
por: Agarwal, Swashti, et al.
Publicado: (2020)

Predictors of reproductive and non-reproductive outcomes of gonadotropin mediated pubertal induction in male patients with congenital hypogonadotropic hypogonadism (CHH)
por: Cangiano, B., et al.
Publicado: (2021)

Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism
por: Lin, Jianli, et al.
Publicado: (2019)

Clinical Characteristics and Spermatogenesis in Patients with Congenital Hypogonadotropic Hypogonadism Caused by FGFR1 Mutations
por: Li, Shuying, et al.
Publicado: (2020)

Evaluating the Combination of Human Chorionic Gonadotropin and Clomiphene Citrate in Treatment of Male Hypogonadotropic Hypogonadism: A Prospective Study
por: Trinh, The Son, et al.
Publicado: (2021)

Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases
por: Gürbüz, Ali Sami, et al.
Publicado: (2020)

Hormonal therapy is effective and safe for cryptorchidism caused by idiopathic hypogonadotropic hypogonadism in adult males
por: Sun, Taotao, et al.
Publicado: (2023)

Application of Human Menopausal Gonadotropins in the Treatment of Idiopathic Hypogonadotropic Hypogonadism (IHH)-Based Infertility in Females: A Case Report
por: Ma, Ying-Jie, et al.
Publicado: (2023)

Gonadotropin-Induced Spermatogenesis in CHH Patients with Cryptorchidism
por: Liu, Zhaoxiang, et al.
Publicado: (2019)

Psychological Aspects of Congenital Hypogonadotropic Hypogonadism
por: Dwyer, Andrew A., et al.
Publicado: (2019)

Congenital hypogonadotropic hypogonadism complicated by neuroblastoma
por: Ueta, Yukiko, et al.
Publicado: (2022)

Treatment of congenital hypogonadotropic hypogonadism in male patients
por: Lee, Hae Sang, et al.
Publicado: (2022)

The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility
por: Borgert, Benjamin J, et al.
Publicado: (2023)

Progress and Challenges in the Search for the Mechanisms of Pulsatile Gonadotropin-Releasing Hormone Secretion
por: Constantin, Stephanie
Publicado: (2017)

Pulsatile gonadotropin-releasing hormone: clinical applications of a physiologic paradigm
por: Filicori, Marco
Publicado: (2023)

The diagnostic value of the olfactory evaluation for congenital hypogonadotropic hypogonadism
por: Yu, Bingqing, et al.
Publicado: (2022)

Gonadotropin administration to mimic mini-puberty in hypogonadotropic males: pump or injections?
por: Avril, Tristan, et al.
Publicado: (2023)

A partial loss-of-function variant in GNRNR gene in a Chinese cohort with idiopathic hypogonadotropic hypogonadism
por: Chen, Yinwei, et al.
Publicado: (2021)

Beyond hormone replacement: quality of life in women with congenital hypogonadotropic hypogonadism
por: Dzemaili, Shota, et al.
Publicado: (2017)

NDNF variants are rare in patients with congenital hypogonadotropic hypogonadism
por: Tamaoka, Satoshi, et al.
Publicado: (2021)

New findings in oligogenic inheritance of congenital hypogonadotropic hypogonadism
por: Gach, Agnieszka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6nq9og0iml4nr1e1gcs3fjtcge